Familial and hereditary pancreatic cancer in Japan.

Abstract excerpt

As in Western countries, familial pancreatic cancer accounts for 5-7% of pancreatic cancer (PC) in Japan. Opportunities for diagnosing hereditary pancreatic cancer (HPC) are increasing owing to the coverage of companion diagnostics and cancer genomic profiling by national health insurance in patients with unresectable or recurrent PC refractory to standard chemotherapies. HPC is recognized in 7% of PCs and 15% of...

Topics

Join the communities discussing this publication.

• Carcinoma
• PALB2 gene
• PC gene
• Genetic Predisposition to Disease
• Genetic Testing
• Germ-Line Mutation